Berodual® Respimat® vs Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to compare the effect of 'natural' as opposed to 'optimal' technique on the percentage
of the dose received from the Respimat® inhaler and metered dose inhaler
Phase:
Phase 3
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Fenoterol Fenoterol, ipratropium drug combination Ipratropium